Radiofrequency Technic's Impact on Perineal Postpartum Pain

Sponsor
Assistance Publique Hopitaux De Marseille (Other)
Overall Status
Unknown status
CT.gov ID
NCT03172286
Collaborator
(none)
62
1
2
20.7
3

Study Details

Study Description

Brief Summary

A study in the postpartum period reveals that among women who delivered vaginally and having perineal lesions, between 95 and 100% of them suffer from perineal pain (episiotomy, tears from 1st to 4th degree) to 24 hours of vaginal delivery; and between 60 and 91% 7 days after delivery.

Severe pain that is not taken into account can become chronic pain. It has physical and psychological consequences. It is therefore essential to prevent these risks in young mothers.

The main objective of this study is to assess the efficacy of radiofrequency treatment on perineal pain postpartum, after a vaginal delivery, instrumented or not, in patients with perineal lesions.

A double-blind randomized prospective single-center study will be conducted on patients delivering at Marseille's north hospital.

Women who gave birth to the North hospital site, with perineal lesions (tears, episiotomy) will be invited to enroll in the study.

Patients will be then randomized into two groups, one with radiofrequency treatment, the other without treatment with radiofrequency.

The duration of inclusion is provided over 6 months. Each topic will be followed over a period of 1 month. The total study duration is 7 months.

The expected results are a significant reduction in pain scores during the first days postpartum in women with perineal alteration caused by a vaginal delivery instrumented or not. Also an improvement in the quality of life of patients during the first days.

Condition or Disease Intervention/Treatment Phase
  • Device: Radiofrequencer
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Double blind studyDouble blind study
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Radiofrequency Technic's Impact on Perineal Postpartum Pain
Actual Study Start Date :
Apr 10, 2017
Anticipated Primary Completion Date :
Apr 1, 2018
Anticipated Study Completion Date :
Dec 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Patient treated with fake radiofrequencer

Device: Radiofrequencer
Patients will be treated with a radiofrenquencer switched on or off depending on the attributed group after randomization

Experimental: Patient treated with radiofrequencer

Device: Radiofrequencer
Patients will be treated with a radiofrenquencer switched on or off depending on the attributed group after randomization

Outcome Measures

Primary Outcome Measures

  1. Pain score using analogical pain scale [30 minutes]

    Pain score will be assessed before and after the radiofrequencing cession

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who naturaly delivered with ou without instruments such as Suction cup, spatulas, forceps

  • Patients presenting perineal lesions

Exclusion Criteria:
  • Patients who delivered through cesarean section

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assistance Publique Hôpitaux de Masreille Marseille France 13014

Sponsors and Collaborators

  • Assistance Publique Hopitaux De Marseille

Investigators

  • Study Director: Urielle DESALBRES, Assistance Publique Hôpitaux de Marseille

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier:
NCT03172286
Other Study ID Numbers:
  • 2016-43
  • 2016-A01499-42
First Posted:
Jun 1, 2017
Last Update Posted:
Jun 1, 2017
Last Verified:
Mar 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 1, 2017